NCT04865718

Brief Summary

The purpose of this research study is to evaluate the ability of laser speckle contrast imaging to visualize blood flow in real time during neurosurgery. Real-time blood flow visualization during surgery could help neurosurgeons better understand the consequences of vascular occlusion events during surgery, recognize potential adverse complications, and thus prompt timely intervention to reduce the risk of stroke. The current standard for visualizing cerebral blood flow during surgery is indocyanine green angiography (ICGA), which involves administering a bolus of fluorescent dye intravenously and imaging the wash-in of the dye to determine which vessels are perfused. Unfortunately, ICGA can only be used a few times during a surgery due to the need to inject a fluorescent dye, and provides only an instantaneous view of perfusion rather than a continuous view. Laser speckle contrast imaging does not require any dyes or tissue contact and has the potential to provide complementary information to ICGA. In this study we plant to collect blood flow images with laser speckle contrast imaging and to compare the images with ICGA that is performed as part of routine care during neurovascular surgical procedures such as aneurysm clipping.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2019

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

December 5, 2023

Status Verified

December 1, 2023

Enrollment Period

5.4 years

First QC Date

April 28, 2021

Last Update Submit

December 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • blood flow visible in laser speckle contrast images

    Ability of laser speckle contrast images to reveal blood flow during surgery

    during surgical procedure

Study Arms (1)

neurovascular surgery group

Subjects undergoing neurovascular surgery including aneurysm clipping

Diagnostic Test: ICGA imaging

Interventions

ICGA imagingDIAGNOSTIC_TEST

subjects undergoing intraoperative ICGA imaging

neurovascular surgery group

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will enroll adults planned for craniotomy procedures such as planned resections for brain tumor or neurovascular procedure such as aneurysm or arteriovenous malformation

You may qualify if:

  • Adults (18 years or older).
  • Size of craniotomy at least 2 cm.
  • Possibility of intraoperative ICGA.
  • Able to render written informed consent.

You may not qualify if:

  • Patients unable to legally consent.
  • Patients with impaired cognitive function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dell Seton Medical Center

Austin, Texas, 78701, United States

RECRUITING

MeSH Terms

Conditions

Intracranial AneurysmArteriovenous Malformations

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular DiseasesVascular MalformationsCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Andrew Dunn, PhD

CONTACT

Kristina Adrean, RN

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2021

First Posted

April 29, 2021

Study Start

June 27, 2019

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

December 5, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations